Study: Targeted Approach for Harm Reduction Using E-Cigarettes

Sep.19.2022
Study: Targeted Approach for Harm Reduction Using E-Cigarettes
A study emphasizes the need for e-cigarettes as a harm reduction tool and explores its potential to aid in smoking cessation.

A study published in the Journal of American Drug and Alcohol Abuse reaffirmed the necessity of using electronic cigarettes (EC) as a tool to reduce harm.


The title of this paper is "A Targeted Approach Using E-cigarettes to Reduce Adult Harm", which emphasizes the negative perception of e-cigarettes and the inaccurate belief that they are as harmful as or more harmful than combustible cigarettes, representing a missed opportunity in public health.


This paper outlines the necessity of this view and openly explores the potential use of electronic cigarettes (EC) as a way of reducing harm for smokers who find it difficult to quit. Recent reviews of randomized controlled trials and network meta-analyses on using electronic cigarettes to quit smoking have found that smokers who were given nicotine electronic cigarettes were more likely to stay smoke-free compared to those given permission to use nicotine replacement therapy (NRT).


EC and NRT. (Note: This is already in English and does not require translation.)


The study titled "Systematic Review of Randomized Controlled Trials and Network Meta-analysis Comparing E-Cigarettes to Approved Nicotine Replacement Therapy (NRT) and Non-Nicotine Based Smoking Cessation" examines the effectiveness of nicotine-based e-cigarettes compared to NRT and non-nicotine based methods for quitting smoking. The research analyzes controlled conditions to determine which method is most effective.


Researchers conducted a search in PubMed, Web of Science, and PsycINFO for randomized controlled trials (RCTs) that allocated individuals to use nicotine electronic cigarettes compared to those using licensed nicotine replacement therapy (NRT) such as nicotine patches or gum, or placebo. The study only included research involving healthy smoking participants.


A research team has sifted through thousands of studies and found that smokers who switch to nicotine electronic cigarettes are more likely to quit smoking than those who remain on standard smoking cessation methods. "Smokers allocated to e-cigarettes were more likely to have quit smoking than those allocated to nicotine-replacement therapy, and both were more effective than standard care or placebo conditions. Due to the risk of bias in the studies included, more high-quality research is needed to determine the impact of e-cigarettes on smoking cessation," the study concluded.


Statement:


This article draws from third-party sources and is intended solely for professional industry exchange and learning purposes.


This article does not reflect the views of 2FIRSTS and 2FIRSTS cannot verify the authenticity and accuracy of its content. The translation of this article is only meant for industry exchange and research purposes.


Due to limitations in our ability to accurately translate, the translated article may not faithfully convey the meaning of the original text. We advise readers to refer to the original text for accuracy.


2FIRSTS maintains full alignment with the Chinese government on any domestic, Hong Kong, Macau, Taiwan, or international issues and positions.


The copyright of compiled information belongs to the original media and author, and if there is any infringement, please contact us for removal.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

From the “Starting Point” to Global Compliance: Heno Bio Partners With 2Firsts to Pioneer PMTA
From the “Starting Point” to Global Compliance: Heno Bio Partners With 2Firsts to Pioneer PMTA
Heno Bio—a prominent nicotine enterprise—has partnered with leading new tobacco media and think tank 2Firsts to develop a pioneering roadmap for Premarket Tobacco Product Applications (PMTAs) under the U.S. Food and Drug Administration (FDA). This partnership not only sets a precedent for the entire industry to explore new approaches to compliance, but also underscores Heno Bio’s leadership and responsibility as the “starting point” in the new tobacco supply chain.
Business
Jan.16 by 2Firsts
Philippine Congressman Urges Halt to Flava E-cigarette Sales
Philippine Congressman Urges Halt to Flava E-cigarette Sales
A Philippine congressman seeks to halt the sales of e-cigarette brand Flava, citing unpaid taxes of 800 million pesos.
Business
Dec.14 by 2FIRSTS.ai
Illegal Sale of E-Cigarettes in Brazil: Man Arrested with 33 Devices
Illegal Sale of E-Cigarettes in Brazil: Man Arrested with 33 Devices
Brazilian police seize 33 e-cigarettes and 510 packages from a 52-year-old man's residence in Brasilia for illegal sales.
Regulations
Nov.28 by 2FIRSTS.ai
Massive Invasion: What Prospects Do Leading Vape Brands See in Japan?
Massive Invasion: What Prospects Do Leading Vape Brands See in Japan?
In a market characterized by "credit society," stringent production conditions, and elusive advertising channel partners, entry is far from easy for new tobacco brands. Major players are seizing the opportunity to deploy and expand, driven by the belief in the vast prospects following the relaxation of zero-nicotine restrictions.
Market
Jan.21 by 2FIRSTS, edited by Sophia
Hong Kong mulls drastic measures to further reduce number of smokers, despite record rate drop below 10 per cent
Regulations
Jun.13
BAT to Launch Synthetic Nicotine Pouch Velo Plus in the U.S., Expected in 2025
BAT to Launch Synthetic Nicotine Pouch Velo Plus in the U.S., Expected in 2025
BAT's release of Velo Plus, a synthetic nicotine pouch, marks a first in the tobacco industry. CEO David Waterfield discusses its future prospects.
Oct.17 by 2FIRSTS.ai